Abrdn Healthcare Investors (HQH)

NYSE: HQH · Real-Time Price · USD

21.12

-0.47 (-2.18%)

At close: Jul 13, 2026, 4:00 PM EDT

21.12

0.00 (0.00%)

After-hours: Jul 13, 2026, 7:00 PM EDT

HQH Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Other Revenue	5.54	7.53	10.77	10.29	8.27	6.48
Revenue	5.54	7.53	10.77	10.29	8.27	6.48
Revenue Growth (YoY)	-45.65%	-30.05%	4.64%	24.44%	27.63%	-27.46%
Gross Profit	5.54	7.53	10.77	10.29	8.27	6.48
Selling, General & Admin	11.45	10.75	10.99	11.48	11.94	12.71
Operating Expenses	11.45	10.75	10.99	11.48	11.94	12.71
Operating Income	-5.91	-3.22	-0.22	-1.19	-3.67	-6.23
Currency Exchange Gain (Loss)	-0	0	0	-0	0.01	-0.02
Other Non Operating Income (Expenses)	3.97	2.35	1.61	-	3.27	4.38
EBT Excluding Unusual Items	-1.94	-0.87	1.39	-1.19	-0.39	-1.87
Gain (Loss) on Sale of Investments	254.71	99.48	183.56	57.52	-193.83	157.05
Pretax Income	252.77	98.61	184.95	56.33	-194.23	155.18
Net Income	252.77	98.61	184.95	56.33	-194.23	155.18
Net Income to Common	252.77	98.61	184.95	56.33	-194.23	155.18
Net Income Growth	2326.66%	-46.68%	228.30%	-	-	-35.67%
Shares Outstanding (Basic)	57	56	52	49	47	45
Shares Outstanding (Diluted)	57	56	52	49	47	45
Shares Change (YoY)	6.18%	6.49%	5.44%	4.43%	4.22%	3.54%
EPS (Basic)	4.42	1.78	3.55	1.14	-4.10	3.42
EPS (Diluted)	4.42	1.78	3.55	1.14	-4.10	3.42
EPS Growth	2185.38%	-49.93%	211.37%	-	-	-37.87%
Dividend Per Share	2.250	2.240	2.040	1.610	1.830	2.010
Dividend Growth	-5.06%	9.80%	26.71%	-12.02%	-8.96%	12.92%
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-106.62%	-42.73%	-2.04%	-11.52%	-44.38%	-96.14%
Profit Margin	4561.32%	1309.02%	1717.36%	547.37%	-2348.38%	2394.57%
EBIT	-5.91	-3.22	-0.22	-1.19	-3.67	-6.23
EBIT Margin	-106.62%	-42.73%	-2.04%	-11.52%	-44.38%	-96.14%
Revenue as Reported	5.54	7.53	10.77	10.29	8.27	6.48

SEC Filings: 10-K · 10-Q